We found that tumor mass and time since diagnosis of breast cancer were not associated with the levels of any cytokine; however, the duration of completion of chemotherapy was associated with IL-5 levels (regression coefficient = 0.009; P = 0.043). Here, IL5 is linked to breast cancer.